ResearcherBinzhou Medical UniversityActive in the last 2 years
Ling Zhou
Matched on ORCID iD 0009-0006-1468-7896; OpenAlex author ID A5101849152. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- Tiliroside disrupted iron homeostasis and induced ferroptosis via directly targeting calpain-2 in pancreatic cancer cells. Last author DOI 10.1016/j.phymed.2024.155392↗
- Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells. Co-author DOI 10.1016/j.bcp.2021.114813↗
- Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol. Co-author DOI 10.1208/s12248-013-9558-3↗
- Structure of a polysaccharide from Gastrodia elata Bl., and oligosaccharides prepared thereof with anti-pancreatic cancer cell growth activities Co-author DOI 10.1016/j.carbpol.2011.06.029↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maolei Xu · 2 shared papers, 2021–2024 · strength 0.33
- Paper Tiliroside disrupted iron homeostasis and induced ferroptosis via directly targeting calpain-2 in pancreatic cancer cel… DOI 10.1016/j.phymed.2024.155392↗
- Paper Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancre… DOI 10.1016/j.bcp.2021.114813↗
- Yufu Zhou · 1 shared paper, 2024 · strength 0.19
- Chen Yang · 1 shared paper, 2021 · strength 0.14
- Ping Li · 1 shared paper, 2014 · strength 0.05
- Xiaojun Xu · 1 shared paper, 2014 · strength 0.05
- Xia Chen · 1 shared paper, 2011 · strength 0.03
- Kan Ding · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.